Crossmark

Immunoglobulin A Glycosylation and Its Role in Disease

Crossref DOI link: https://doi.org/10.1007/978-3-030-76912-3_14

Published Online: 2021-10-23

Published Print: 2021

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hansen, Alyssa L.

Reily, Colin

Novak, Jan

Renfrow, Matthew B.
License Information

Text and Data Mining valid from 2021-01-01

Version of Record valid from 2021-01-01

Text and Data Mining valid from 2021-01-01

Version of Record valid from 2021-01-01
More Information

Chapter History

First Online: 23 October 2021

Compliance with Ethical Standards

:

: The authors of this study were supported in part by NIH grants AR069516, DK106341, CD122194, GM098539, DK078244, and DK082753 and by a gift from the IGA Nephropathy Foundation of America.

: MBR and JN are co<i>-</i>founders and co<i>-</i>owners of and consultants for Reliant Glycosciences, LLC. MBR and JN are co-inventors on US patent application 14/318,082 (assigned to UAB Research Foundation). ALH and CR declare no conflict of interest.

: Not applicable, as this is a review article and, thus, there are no human subjects recruited for this study or any animals used.

: Not applicable, as this is a review article and, thus, there are no human subjects recruited for this study.